Some previous observations advanced the notion that disruption of the ANP/NPRA/cGMP signaling pathway can augment activation of proinflammatory cytokines leading to extracellular matrix remodeling, pathological hypertrophy, and CHF. This evidence concerns the gene NPR1 and congestive heart failure.